| 2019 | Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia | 정혜경; 문영철; 박상희 | Article |
| 2021 | Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and F-18-FDG PET/CT | 문영철 | Article |
| 2007 | Early imatinib mesylate-induced hepatotoxicity in chronic myelogenous leukaemia | 이순남; 성주명; 조민선; 이경은; 문영철; 남은미 | Article |
| 2017 | EARLY PREDICTION OF THE MOLECULAR RESPONSE TO BCR-ABL1 TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 문영철 | Meeting Abstract |
| 2013 | Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation | 문영철 | Article |
| 2014 | Effect of anemia correction on left ventricular structure and filling pressure in anemic patients without overt heart disease | 신길자; 권기환; 문영철 | Article |
| 2023 | Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study | 문영철 | Article |
| 2018 | Efficacy and safety of a new 10% intravenous immunoglobulin product in patients with primary immune thrombocytopenia (ITP) | 문영철 | Article |
| 2016 | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study | 문영철 | Article |
| 2015 | Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial | 문영철 | Meeting Abstract |
| 2013 | Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia | 문영철 | Article |
| 2005 | Establishment of effective B lymphocyte ex vivo expansion on human cord blood using TPO, SCF, FL, IL-4, IL-10, and CD40L | 이순남; 성주명; 이경은; 문영철 | Meeting Abstract |
| 2004 | Establishment of effective B lymphocyte ex vivo expansion on human cord blood using TPO, SCF, FL, IL-4, IL-10, and CD40L. | 이순남; 성주명; 이경은; 문영철 | Meeting Abstract |
| 2014 | ETV6/RUNX1 Rearrangement Identified by RT-PCR without Evidence on FISH | 정화순; 성주명; 허정원; 문영철 | Article in Press |
| 2008 | Final Report of "Korean Multicenter AML-2000 Trial": Intention to Treat Analysis Based on Cytogenctics Risk | 문영철 | Meeting Abstract |
| 2018 | GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms | 이미애; 성주명; 허정원; 조민선; 문영철 | Article |
| 2003 | Gene expression profile related to prognosis of acute myeloid leukemia | 성주명; 이경은; 문영철 | Meeting Abstract |
| 2007 | Gene expression profile related to prognosis of acute myeloid leukemia | 성주명; 이경은; 문영철 | Article |
| 2013 | Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype | 문영철 | Article |
| 2018 | Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients | 문영철 | Article |
| 2013 | Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment | 허정원; 문영철 | Article |
| 2015 | Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression | 정화순; 성주명; 허정원; 문영철 | Article |
| 2012 | Head-to-Head Comparison of 5-Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome | 문영철 | Meeting Abstract |
| 2007 | Hematopoietic stem cells mobilization by G-CSF and LTB4 was significantly suppressed by an oxygen radical scavenger or an inhibitor of NADPH oxidase | 성주명; 유은선; 이경은; 문영철 | Meeting Abstract |
| 2012 | Hepatitis B Virus Reactivation in Chronic Myeloid Leukemia Treated with Various Tyrosine Kinase Inhibitors: Multicenter, Retrospective Study | 문영철 | Meeting Abstract |
| 2016 | Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study | 문영철 | Article |
| 2016 | Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study | 문영철 | Article |
| 2009 | Immunoglobulin D Multiple Myeloma: Clinical Presentation, Response to Therapy and Prognostic Factors in 75 Patients; An Analysis of the Korean Multiple Myeloma Working Party (KMMWP). | 문영철 | Meeting Abstract |
| 2011 | Immunoglobulin D multiple myeloma: Response to therapy, survival, and prognostic factors in 75 patients | 문영철 | Article |
| 2021 | Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma | 문영철 | Article |
